bovnews4h
What’s Causing Vuzix Corp (VUZI) Stock’s 214.13% Jump Over the Last Six Months?
Vuzix Corp (VUZI) stock saw a modest uptick, ending the day at $4.22 which represents a slight increase of $0.11 or 2.68% from the prior close of $4.11. The stock opened at $4.08 and touched a low of ...
24/7 Wall St. on MSN2d
Large-Cap Value Stocks Could Rule in 2025: 4 High-Yield Dividend Winners
According to BTIG Research, value stocks are closing at a 40-year low relative to growth. The primary reason is that ...
Why Frontline plc (FRO) Is Skyrocketing
Frontline plc (NYSE:FRO) is a company engaged in seaborne transportation of crude oil and refined products. The company owns ...
bovnews2d
BTIG Research Just Downgraded Fiverr International Ltd (FVRR) Stock—What Does This Mean for Investors?
BTIG Research has recently reduced Fiverr International Ltd (FVRR) stock to Neutral rating, as announced on November 4, 2024, according to Finviz. Earlier, on July 2, 2024, UBS had reduced the stock ...
Frontline plc (NYSE:FRO) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Shares of Frontline plc (NYSE:FRO – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six ...
BTIG Sticks to Their Buy Rating for Stryker (SYK)
BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker (SYK – Research Report) yesterday and set a price target of $394.00. The ...
Denali Therapeutics price target lowered to $32 from $35 at BTIG
BTIG analyst Thomas Shrader lowered the firm’s price target on Denali Therapeutics (DNLI) to $32 from $35 and keeps a Buy rating on the shares after the company announced topline data from the Phase 2 ...
Carisma Therapeutics, Inc. (NASDAQ:CARM) Receives $4.94 Average PT from Analysts
Carisma Therapeutics, Inc. (NASDAQ:CARM – Get Free Report) has earned an average recommendation of “Hold” from the seven ...
Nasdaq1mon
DoorDash price target raised to $200 from $175 at BTIG
the analyst tells investors in a research note. BTIG adds that the growth-adjusted valuation on DoorDash shares is reasonable relative to large cap consumer-facing Internet. TipRanks is the most ...
Glaukos price target raised to $157 from $149 at BTIG
BTIG raised the firm’s price target on Glaukos (GKOS) to $157 from $149 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models on Medical Technology names ...
Hosted on MSN11h
BTIG Downgrades Palo Alto Networks (PANW)
Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Palo Alto Networks (NasdaqGS:PANW) from Buy to Neutral. Analyst Price Forecast Suggests 22.11% Upside As of December 23, 2024, ...